Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.16369 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.14334 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.14215 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.07075 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.12658 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.18303 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.17992 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.12533 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.12065 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.13821 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.12632 | 7 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.11275 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.13504 | 7 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.13359 | 7 |